Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Colorcon
Medtronic
Dow
McKinsey
Merck
Mallinckrodt

Last Updated: September 26, 2022

COGENTIN Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


Which patents cover Cogentin, and when can generic versions of Cogentin launch?

Cogentin is a drug marketed by Akorn and Merck and is included in two NDAs.

The generic ingredient in COGENTIN is benztropine mesylate. There are seven drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the benztropine mesylate profile page.

Summary for COGENTIN
Drug patent expirations by year for COGENTIN
Drug Prices for COGENTIN

See drug prices for COGENTIN

Recent Clinical Trials for COGENTIN

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of California, San DiegoPhase 2
National Institute of Mental Health (NIMH)Phase 4
AstraZenecaPhase 4

See all COGENTIN clinical trials

US Patents and Regulatory Information for COGENTIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Akorn COGENTIN benztropine mesylate INJECTABLE;INJECTION 012015-001 Approved Prior to Jan 1, 1982 DISCN Yes No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Merck COGENTIN benztropine mesylate TABLET;ORAL 009193-002 Approved Prior to Jan 1, 1982 DISCN Yes No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Merck COGENTIN benztropine mesylate TABLET;ORAL 009193-004 Approved Prior to Jan 1, 1982 DISCN Yes No See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
McKesson
Moodys
Dow
McKinsey
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.